Symbicort SMART Satisfaction From Patient Perspective 2009

AstraZeneca205 enrolled

Overview

To characterize the level of asthma control and patient satisfaction amongst diagnosed asthma sufferers who are currently receiving Symbicort Maintenance and Reliever Therapy (SMART) in Malaysia.

Study Type

OBSERVATIONAL

Enrollment

205

Conditions

Asthma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 59 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Have been prescribed Symbicort SMART (1 or 2 inhalation twice daily) by their Dr's for the past 3 months * Informed consent Exclusion Criteria: * Symbicort SMART treatment \< 3 months * Patients requiring short courses of oral steroids more than twice in a month

Locations (1)

Research Site

Petaling Jaya, Selangor, Malaysia

Outcomes

Primary Outcomes

Score level of Satisfaction in Asthma Treatment Questionnaire (SATQ)

Time frame: After 3 months on SMART - once

Score level of Asthma Control Test (ACT)

Time frame: After 3 months on SMART - once

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.